このアイテムのアクセス数: 283

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
33_329.pdf358.57 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.author郷司, 和男ja
dc.contributor.author浜見, 学ja
dc.contributor.author守殿, 貞夫ja
dc.contributor.alternativeGOHJI, Kazuoen
dc.contributor.alternativeHAMAMI, Gakuen
dc.contributor.alternativeKAMIDONO, Sadaoen
dc.date.accessioned2010-06-02T02:18:55Z-
dc.date.available2010-06-02T02:18:55Z-
dc.date.issued1987-03-
dc.identifier.issn0018-1994-
dc.identifier.urihttp://hdl.handle.net/2433/119084-
dc.description.abstractThe inhibitory effect of human-recombinant tumor necrosis factor (Hu-rec-TNF) alone or in combination with human recombinant gamma-interferon (rec gamma-IFN), doxorubicin (ADM) or cis-platinum (CDDP) was studied for two human renal cell carcinoma lines (KO-RCC-1 and RCC-nu-1 cells). Hu-rec-TNF inhibited the cell growth of KO-RCC-1 cells in a dose- and time-dependent manner. The inhibitory effect was seen 48 hours after the treatment with Hu-rec-TNF alone. The effect of Hu-rec-TNF was cytotoxic in our experiment. On the other hand, Hu-rec-TNF did not inhibit the cell growth of RCC-nu-1 cells. There were sensitive and resistant cells in renal cell carcinoma. In KO-RCC-1 cells, Hu-rec-TNF enhanced the inhibitory effect of rec gamma-IFN, ADM or CDDP. On the other hand, Hu-rec-TNF did not enhance the inhibitory effect of rec gamma-IFN, ADM or CDDP in RCC-nu-1 cells. In our experiment, the combined treatment with Hu-rec-TNF and rec gamma-IFN, ADM or CDDP was useful in human renal cell carcinoma which was sensitive for Hu-rec-TNF.en
dc.format.mimetypeapplication/pdf-
dc.language.isojpn-
dc.publisher泌尿器科紀要刊行会ja
dc.subjectHuman recombinant TNFen
dc.subjectRenal cell carcinomaen
dc.subject.ndc494.9-
dc.titleヒト腎細胞癌培養株細胞に対する遺伝子組み換えヒトTNFの抗腫瘍活性および遺伝子組み換えヒトγ-lnterferon,Doxorubicin,Cis-platinumとの併用効果ja
dc.title.alternativeAnti-neoplastic activity of a human recombinant tumor necrosis factor (Hu-rec-TNF) alone or in combination with human recombinant gamma-interferon, doxorubicin or cis-platinum on a human renal cell carcinoma lineen
dc.typedepartmental bulletin paper-
dc.type.niitypeDepartmental Bulletin Paper-
dc.identifier.ncidAN00208315-
dc.identifier.jtitle泌尿器科紀要ja
dc.identifier.volume33-
dc.identifier.issue3-
dc.identifier.spage329-
dc.identifier.epage335-
dc.textversionpublisher-
dc.sortkey01-
dc.address神戸大学医学部泌尿器科学教室ja
dc.address神戸大学医学部泌尿器科学教室ja
dc.address神戸大学医学部泌尿器科学教室ja
dc.address.alternativeDepartment of Urology, Kobe University School of Medicineen
dc.address.alternativeDepartment of Urology, Kobe University School of Medicineen
dc.address.alternativeDepartment of Urology, Kobe University School of Medicineen
dc.identifier.pmid3113191-
dcterms.accessRightsopen access-
dc.identifier.pissn0018-1994-
dc.identifier.jtitle-alternativeActa urologica Japonicala
dc.identifier.jtitle-alternativeHinyokika Kiyoen
出現コレクション:Vol.33 No.3

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。